Percutaneous transcatheter heart valve implantation in a bicuspid aortic valve.

Chiam PT, Chao VT, Tan SY, Koh TH, Lee CY, See Tho VY, Chua YL.

Journal of the American College of Cardiology Interventions 2010; 3: 559-61.

A 77-year-old man presented with increasingly symptomatic severe aortic stenosis (AS). Echocardiogram showed an aortic valve area of 0.6 cm² and a mean pressure gradient of 57 mm Hg. It could not be ascertained conclusively if the valve was tricuspid or bicuspid due to heavy calcification (Figs. 1A and 1B). Aortic annulus was 20 mm in diameter. Left ventricular ejection fraction was 40%. At cardiac catheterization, calcified leaflets were seen but it could not be determined if the valve was tricuspid on aortogram (Figs. 2A and2B). Cardiac computed tomography angiography (CTA), however, conclusively revealed a stenosed bicuspid aortic valve (Figs. 3A to 3C). Due to prohibitive perioperative risk, the patient was declined for surgery. Although bicuspid AS is a contraindication in the ongoing PARTNER (Placement of AoRTic TraNscathetER valves) trial, anecdotal experience suggests that percutaneous valve implantation is feasible (J. Webb, personal communication, February 2009). After balloon valvuloplasty, a 23-mm Sapien transcatheter heart valve (THV) (Edwards Lifesciences, Irvine, California) was successfully deployed via the transfemoral route. The patient was well at 6 months with marked improvement in functional status. Echocardiogram showed left ventricular ejection fraction of 46%, mean pressure gradient of 20 mm Hg across the aortic valve, and trivial paravalvular leak. Both the echocardiogram and cardiac CTA revealed a circular, well-expanded prosthesis (Figs. 4A and 4B).

Diagram showing the components and placement of a Left Ventricular Assist Device (LVAD)

What Is an Artificial Heart Pump (LVAD) and Who Needs One?

For patients with advanced heart failure, medications alone may no longer be enough to help the heart pump blood effectively. A Left Ventricular Assist Device (LVAD), often referred to as an artificial heart pump, can help improve blood flow, relieve symptoms, and enhance quality of life. Learn how LVADs work, who may benefit from them, and what to expect before, during and after implantation.

Middle-aged Asian man clutching his chest, appearing to experience chest pain or symptoms of cardiac arrest.

Can Healthy Individuals Get Cardiac Arrest?

Even seemingly healthy individuals without known heart conditions can experience cardiac arrest. Recognising risk factors and adopting a heart-healthy lifestyle, including regular exercise, a balanced diet, avoiding smoking, limiting alcohol intake, managing stress and going for health screening regularly, can potentially reduce the risk.

Leaky tricuspid valve (tricuspid regurgitation) showing backward blood flow from the right ventricle into the right atrium

Minimally Invasive Treatment Options for Leaky Tricuspid Valve

A leaky tricuspid valve, also known as tricuspid regurgitation, is a heart valve condition that can cause swelling, breathlessness, fatigue, and worsening heart failure if left untreated. While open-heart surgery was once the only definitive treatment, advances in heart valve technology now allow selected patients to be treated using minimally invasive catheter-based procedures, including tricuspid transcatheter edge-to-edge repair, transcatheter tricuspid valve replacement, and caval valve implantation.

the connection between sleep problems and heart failure

The Hidden Connection between Sleep Problems and Heart Failure

Sleep problems are common among people with heart failure, and research shows the relationship goes both ways. Conditions such as obstructive sleep apnoea (OSA) and insomnia can worsen heart failure symptoms, while heart failure itself often leads to disturbed or poor-quality sleep. Recognising this two-way connection is an important step toward better symptom control and long-term heart health.

Percutaneous transcatheter heart valve implantation in a bicuspid aortic valve.